# Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients

> **NCT00830102** · PHASE2 · COMPLETED · sponsor: **SkyePharma AG** · enrollment: 64 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone propionate, formoterol fumarate
- **DRUG:** fluticasone propionate, formoterol fumarate
- **DRUG:** fluticasone propionate, formoterol fumarate
- **DRUG:** fluticasone propionate, formoterol fumarate
- **DRUG:** fluticasone propionate, formoterol fumarate
- **DRUG:** fluticasone propionate, formoterol fumarate

## Key facts

- **NCT ID:** NCT00830102
- **Lead sponsor:** SkyePharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830102, "Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00830102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*